Literature DB >> 30125729

Osteoblast derived-neurotrophin‑3 induces cartilage removal proteases and osteoclast-mediated function at injured growth plate in rats.

Yu-Wen Su1, Shek Man Chim2, Lin Zhou3, Mohammadhossein Hassanshahi4, Rosa Chung5, Chiaming Fan6, Yunmei Song7, Bruce K Foster8, Clive A Prestidge9, Yaser Peymanfar10, Qian Tang11, Lisa M Butler12, Stan Gronthos13, Di Chen14, Yangli Xie15, Lin Chen15, Xin-Fu Zhou16, Jiake Xu17, Cory J Xian18.   

Abstract

Faulty bony repair causes dysrepair of injured growth plate cartilage and bone growth defects in children; however, the underlying mechanisms are unclear. Recently, we observed the prominent induction of neurotrophin‑3 (NT-3) and its important roles as an osteogenic and angiogenic factor promoting the bony repair. The current study investigated its roles in regulating injury site remodelling. In a rat tibial growth plate drill-hole injury repair model, NT-3 was expressed prominently in osteoblasts at the injury site. Recombinant NT-3 (rhNT-3) systemic treatment enhanced, but NT-3 immunoneutralization attenuated, expression of cartilage-removal proteases (MMP-9 and MMP-13), presence of bone-resorbing osteoclasts and expression of osteoclast protease cathepsin K, and remodelling at the injury site. NT-3 was also highly induced in cultured mineralizing rat bone marrow stromal cells, and the conditioned medium augmented osteoclast formation and resorptive activity, an ability that was blocked by presence of anti-NT-3 antibody. Moreover, NT-3 and receptor TrkC were induced during osteoclastogenesis, and rhNT-3 treatment activated TrkC downstream kinase Erk1/2 in differentiating osteoclasts although rhNT-3 alone did not affect activation of osteoclastogenic transcription factors NF-κB or NFAT in RAW264.7 osteoclast precursor cells. Furthermore, rhNT-3 treatment increased, but NT-3 neutralization reduced, expression of osteoclastogenic cytokines (RANKL, TNF-α, and IL-1) in mineralizing osteoblasts and in growth plate injury site, and rhNT-3 augmented the induction of these cytokines caused by RANKL treatment in RAW264.7 cells. Thus, injury site osteoblast-derived NT-3 is important in promoting growth plate injury site remodelling, as it induces cartilage proteases for cartilage removal and augments osteoclastogenesis and resorption both directly (involving activing Erk1/2 and substantiating RANKL-induced increased expression of osteoclastogenic signals in differentiating osteoclasts) and indirectly (inducing osteoclastogenic signals in osteoblasts).
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Growth plate injury; Injury site remodelling; Neurotrophic factors; Signal crosstalk

Mesh:

Substances:

Year:  2018        PMID: 30125729      PMCID: PMC6550307          DOI: 10.1016/j.bone.2018.08.010

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  5 in total

Review 1.  [Research progress of Schwann cells regulating bone regeneration].

Authors:  Xiaoyu Wang; Rui Zhang; Yifan Yu; Jia Xu; Qinglin Kang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2022-02-15

2.  Macrophage-derived neurotrophin-3 promotes heterotopic ossification in rats.

Authors:  Jie Zhang; Liang Wang; Jun Chu; Xiang Ao; Tao Jiang; Minjun Huang; Zhongmin Zhang
Journal:  Lab Invest       Date:  2020-01-02       Impact factor: 5.662

3.  Neurotrophin-3 acts on the endothelial-mesenchymal transition of heterotopic ossification in rats.

Authors:  Jie Zhang; Liang Wang; He Cao; Nan Chen; Bin Yan; Xiang Ao; Huiyu Zhao; Jun Chu; Minjun Huang; Zhongmin Zhang
Journal:  J Cell Mol Med       Date:  2019-01-22       Impact factor: 5.310

4.  Exosome-loaded extracellular matrix-mimic hydrogel with anti-inflammatory property Facilitates/promotes growth plate injury repair.

Authors:  Pengfei Guan; Can Liu; Denghui Xie; Shichao Mao; Yuelun Ji; Yongchang Lin; Zheng Chen; Qiyou Wang; Lei Fan; Yongjian Sun
Journal:  Bioact Mater       Date:  2021-09-16

Review 5.  Nervous System-Driven Osseointegration.

Authors:  Ruoyue Sun; Long Bai; Yaru Yang; Yanshu Ding; Jingwen Zhuang; Jingyuan Cui
Journal:  Int J Mol Sci       Date:  2022-08-10       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.